Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT02331602
Eligibility Criteria:
Inclusion Criteria:
* non-valvular atrial fibrillation
* a CHADS2-VASc score of 1 or more
Exclusion Criteria:
* contraindication for rivaroxaban or dabigatran
* stroke or systemic embolism, acute coronary syndromes or peripheral artery disease within 6 months before enrollment
* acute heart failure
* severe chronic renal failure (creatinine clearance \< 30mL/min.)
* receiving dual antiplatelet therapy
* patients with a body weight of 50kg or less
* uncontrolled hypertension
* active malignancy, collagen disease, or infectious disease
* patients undergoing surgery within 6 months before enrollment
* patients who are planned to undergoing catheter ablation for atrial fibrillation
* patients who are not allowed to participate in the trial by judgement of the treating physician
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
90 Years
Study:
NCT02331602
Study Brief:
Protocol Section:
NCT02331602